Our study shows that the TIAR/LOXL1‐AS1/miR‐374b‐5p/MMP14 axis has significant effects in regulating VM in glioma, which could help reveal novel targets for glioma therapy. This evidence concerns the gene LOXL1 and central nervous system cancer.